HuGE Literature Finder
Records
1
-
5
| The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. Urologic oncology 2022 4 40 (5): 198.e1-198.e8. Gakis Georgios, Perner Sven, Stenzl Arnulf, Renninger Mark |
| DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. The Prostate 2015 9 75 (15): 1790-801. Horning Aaron M, Awe Julius A, Wang Chiou-Miin, Liu Joseph, Lai Zhao, Wang Vickie Yao, Jadhav Rohit R, Louie Anna D, Lin Chun-Lin, Kroczak Tad, Chen Yidong, Jin Victor X, Abboud-Werner Sherry L, Leach Robin J, Hernandez Javior, Thompson Ian M, Saranchuk Jeff, Drachenberg Darrel, Chen Chun-Liang, Mai Sabine, Huang Tim Hui-Mi |
| Importance of 5a-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 576-84. Lévesque Éric, Laverdière Isabelle, Lacombe Louis, Caron Patrick, Rouleau Mélanie, Turcotte Véronique, Têtu Bernard, Fradet Yves, Guillemette Chant |
| SRD5A polymorphisms and biochemical failure after radical prostatectomy. European urology 2011 Dec 60 (6): 1226-34. Audet-Walsh Etienne, Bellemare Judith, Nadeau Geneviève, Lacombe Louis, Fradet Yves, Fradet Vincent, Huang Shu-Pin, Bao Bo-Ying, Douville Pierre, Girard Hugo, Guillemette Chantal, Lévesque Er |
| V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology 2001 Jan 57 (1): 199-204. Nam R K, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett M A, Narod S |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: